Pfizer Inc (NYSE:PFE)

Add to Watch List

43.93

Delayed Data

As of Sep 24

-0.13 / -0.30%

Today’s Change

33.20

Today|||52-Week Range

44.46

+21.29%

Year-to-Date

Latest PFE News | Press Releases

Pfizer (PFE) Gains As Market Dips: What You Should Know Sep 21 / Zacks.com - Paid Partner Content	Is Artificial Intelligence the Next Big Thing in Biotech? Sep 17 / Zacks.com - Paid Partner Content
Pfizer's Pneumococcal Vaccine Gets Breakthrough Therapy Status Sep 21 / Zacks.com - Paid Partner Content	Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know Sep 14 / Zacks.com - Paid Partner Content
Dow 30 Stock Roundup: JPMorgan Ups Dividend, Disney's ESPN+ Hits 1M Paid Subscribers Sep 21 / Zacks.com - Paid Partner Content	Pharma Stock Roundup: AZN's Leukemia Drug Wins FDA Nod, MRK's Keytruda in Focus Sep 14 / Zacks.com - Paid Partner Content
Eli Lilly Prices Animal Health Unit IPO at $24 Per Share Sep 20 / Zacks.com - Paid Partner Content	Pharma/Biotech Stocks to Watch This Prostate Cancer Month Sep 14 / Zacks.com - Paid Partner Content
Merck or Pfizer: Which is the Better Large-Cap Pharma Stock? Sep 20 / Zacks.com - Paid Partner Content	Dow 30 Stock Roundup: Apple Unveils 3 New iPhones, Boeing Clinches $2.9B Deal Sep 14 / Zacks.com - Paid Partner Content
J&J Files NDA for Erdafitinib in Urothelial Cancer Indication Sep 19 / Zacks.com - Paid Partner Content	A Brawl Is Brewing Between AbbVie and Gilead Sciences in Arthritis Sep 14 / MotleyFool.com - Paid Partner Content
Is the Options Market Predicting a Spike in Pfizer (PFE) Stock? Sep 18 / Zacks.com - Paid Partner Content	3 Lung Cancer Stocks That Could End September on a High Note Sep 13 / MotleyFool.com - Paid Partner Content
Can Pfizer (PFE) Bank on Bavencio for Long-Term Growth? Sep 18 / Zacks.com - Paid Partner Content	Pfizer's Drug Combo Betters Survival in Kidney Cancer Study Sep 12 / Zacks.com - Paid Partner Content
Pfizer's Skin Disease Candidates Positive in Mid-Stage Study Sep 17 / Zacks.com - Paid Partner Content	3 Small Biotech Stocks That Almost Doubled in Past Month Sep 11 / Zacks.com - Paid Partner Content
Glaxo Seeks EU Approval for Two-Drug Regimen in First-Line HIV Sep 17 / Zacks.com - Paid Partner Content